Site search

Atopic Dermatitis Research study

The research study is testing an investigational product called TAVO101 designed specifically for people diagnosed with moderate to severe atopic dermatitis (eczema),

Nemolizumab for the treatment of moderate to severe atopic dermatitis Research study

A clinical trial to assess safety and effectiveness of a new drug for eczema called nemolizumab.

Thinking about donating a kidney

Considering donating a kidney? We have a dedicated team of of experts who can answer your questions and guide you through the decision to become a kidney donor.

Cognitive Dementia and Memory Service RMH Service

We provide diagnosis and support to people experiencing changes in their thinking, behaviour or memory.

Donanemab in early symptomatic Alzheimer’s disease Research study

A study to determine the safety and efficacy of a drug called donanemab in treating or delaying the progression of Alzheimer’s dementia.

Home dialysis

The Home Dialysis service is based at the RMH Royal Park and supports both peritoneal dialysis and home haemodialysis.

The RMH Chief Executive tours Parkville Station alongside Government and precinct partners News article

The RMH’s Chief Executive Prof Shelley Dolan, joined the Premier, Minister for Health, and Minister for Public Transport to tour the new Parkville Station and celebrate the early opening of the Parkville Station pedestrian underpass.

Centre for Clinical Pastoral Education

Clinical Pastoral Education is an experiential educational process set within the context of direct spiritual and pastoral care.

Continuous glucose monitoring

We offer a continuous glucose monitoring service for our patients.

Critical Care, Resuscitation and Airway Skills in High Fidelity Simulation (CRASH)

The Critical Care, Resuscitation and Airway Skills in High Fidelity Simulation (CRASH) course is designed to support anaesthetists returning to work. It provides a safe, supportive environment to revise key skills, rehearse critical scenarios and rebuild confidence before resuming clinical...

Health Hub portal

Our Health Hub patient portal is a secure mobile and web application that allows you to see and manage information about your care at the Royal Melbourne Hospital and other Parkville health services.

Combination treatment for locally advanced or metastatic ER-positive breast cancer Research study

A phase II, multicentre, randomised study to compare the efficacy of venetoclax plus fulvestrant as a combination treatment for locally advanced or metastatic ER-positive breast cancer.

Addressing the elephant in the room this R U OK Day News article

Today is R U OK Day, and today we’re addressing a very special elephant in the room.

Health Hub leading to improved patient health outcomes News article

A survey conducted earlier this year of Parkville precinct patients and carers found technology has improved their overall health.

Meg reunited with paramedics after 100 days at the RMH News article

Former patient Meg was reunited with the paramedics who helped save her life.

The RMH anaesthetics registrar wins Heart Foundation 2023 Vanguard Grant News article

Congratulations to the RMH Anaesthetics Registrar and University of Melbourne Honorary Senior Research Fellow Dr Luke Perry, who, with research colleagues, received a 2023 Vanguard Grant from the National Heart Foundation.

Carly Findlay shares her story this International Day of People with Disability News article

Carly Findlay OAM is a patient at the Royal Melbourne Hospital - she’s been a patient here for around 17 years, and before that, she was a patient at the Royal Children’s Hospital. 

Our wards

Our Kidney Care wards care for people with kidney disease, kidney transplants and acute and chronic dialysis and plasma exchange treatments. 

A lifesaving journey from the UK to Australia News article

A young Melbourne man who battled aggressive cancer for over a decade has met the stranger who saved his life … from the other side of the world.

ANAVEX®2-73 for mild cognitive impairment or early Alzheimer’s disease Research study

 A clinical trial that aims to assess the safety and efficacy of a new drug (ANAVEX®2-73) for the treatment of early Alzheimer’s disease.